-
ESTIMATING THE VALUE-BASED PRICE OF EPCORITAMAB VERSUS POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN EGYPT: A COST-UTILITY MODEL
Aug 11, 2026, 17:15 PM -
DIGITAL TRANSFORMATION IN OBESITY CARE: EVALUATING THE IMPACT OF A HYBRID DIGITAL CARE PATHWAY ON NHS CAPACITY IN SOUTH EAST LONDON?
Aug 11, 2026, 17:15 PM -
PROJECTED IMPACT OF PERSONALIZED MRNA NEOANTIGEN VACCINES ON MELANOMA RECURRENCE IN MEDICARE BENEFICIARIES: A PARAMETRIC SURVIVAL AND THRESHOLD COST-EFFECTIVENESS ANALYSIS
Aug 11, 2026, 17:15 PM -
INCIDENCE, TREATMENT AND OVERALL SURVIVAL OF PATIENTS WITH METASTATIC SOLID TUMORS IN GERMANY: A CLAIMS DATA ANALYSIS
Aug 11, 2026, 17:15 PM -
CAPTURING WHAT MATTERS: CO-CREATING A GLOBAL SURVEY ON NEUROLOGICAL IMPACT AND UNMET NEEDS IN GAUCHER DISEASE TYPE 3
Aug 11, 2026, 17:15 PM -
INCREASING COSTS AND LIMITED MORTALITY IMPROVEMENT IN INCIDENT METASTATIC LUNG CANCER IN GERMAN STATUTORY HEALTH INSURANCE CLAIMS, 2011-2024
Aug 11, 2026, 17:15 PM -
A PATIENT PROFILING TOOL TO OPTIMIZE SURGICAL VALVE SELECTION FOR VALVE REPLACEMENT IN EGYPT
Aug 11, 2026, 17:15 PM -
SHIFTS IN TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS IN NMOSD FOLLOWING INTRODUCTION OF APPROVED THERAPIES POST-2019
Aug 11, 2026, 17:15 PM -
EUROPEAN PUBLIC PREFERENCES FOR HEALTHCARE REIMBURSEMENT DECISION CRITERIA: RESULTS FROM AN EIGHT-COUNTRY DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:15 PM -
HEALTHCARE VALUE FRAMEWORK: MAXIMISING OUTCOMES VS SPEND: SEGMENTATION-, CARE-GAP- AND ROI-LED
Aug 11, 2026, 17:15 PM -
THE HIDDEN COSTS OF CONFIDENTIAL REBATES : A MULTI-LEVEL RISK ANALYSIS OF THE FRENCH 'OUT-OF-DRG' HOSPITAL FINANCING SYSTEM
Aug 11, 2026, 17:15 PM -
HEALTHCARE RESOURCE USE AND COST OF CHOROIDAL MELANOMA: A REAL-WORLD RETROSPECTIVE COHORT STUDY FROM NATIONAL HEALTH SERVICE (NHS) ENGLAND PERSPECTIVE
Aug 11, 2026, 17:15 PM -
OPTIMIZING CANCER CARE DELIVERY IN ARGENTINA: INSTITUTIONAL BUDGET AND CAPACITY IMPACT OF SUBCUTANEOUS PEMBROLIZUMAB
Aug 11, 2026, 17:15 PM -
REGRESSION-BASED ASSESSMENT OF INCREASED LENGTH OF STAY DUE TO DRPS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
Aug 11, 2026, 17:15 PM -
PUBLIC HEALTH AND ECONOMIC IMPACT OF PCV21 ON PNEUMOCOCCAL DISEASE IN ADULT NATIONAL IMMUNIZATION PROGRAMME IN DENMARK
Aug 11, 2026, 17:15 PM -
AN OVERVIEW OF UNANCHORED INDIRECT TREATMENT COMPARISON METHODS IN NICE SINGLE TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF HOME PARENTERAL NUTRITION PROGRAMME IMPLEMENTATION: A BUDGET IMPACT ANALYSIS IN ROMANIA
Aug 11, 2026, 17:15 PM -
COMPARATIVE EFFECTIVENESS OF RUXOLITINIB CREAM VERSUS CONVENTIONAL SYSTEMIC IMMUNOSUPPRESSANTS IN MODERATE ATOPIC DERMATITIS: A TARGET TRIAL EMULATION USING A-STAR
Aug 11, 2026, 17:15 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON OF SUBCUTANEOUS IMMUNOGLOBULIN IGPRO20 AND EFGARTIGIMOD IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Aug 11, 2026, 17:15 PM -
MOCK EAG-STYLE REVIEWS USING GENERATIVE AI TO ANTICIPATE HTA CRITIQUE
Aug 11, 2026, 17:15 PM
